Navigation Links
Health Robotics Reaches 100% Asia-Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea
Date:11/12/2009

BOZEN, SUD-TYROL, Italy, November 12 /PRNewswire/ -- Health Robotics today announced that Innomed/BioRobotics, on the heels of its prior market success with Oncology Surgery robots, has exclusively selected Health Robotics' CytoCare(TM) Robot to reach its objective to become the gold standard for Oncology Robotics IV Admixtures in the Republic of Korea and synergistically provide an end-to-end Cancer Robotics solution.

"We are very pleased to reach 100% territorial coverage for CytoCare in Asia-Pacific. This new partnership culminates a great year for Health Robotics' CytoCare adoption and unprecedented market success versus our competition, on the heels of similar new partnerships signed this Summer and Fall in Oceania, China, Taiwan, and South East Asia. In these difficult economic times and at a moment where our competitors are in retreat and total disarray, we have increased our lead in product superiority, expanded our reach worldwide, and are now posed to reap benefits in years to come. We welcome BioRobotics to our family of strategic channel partners and look forward to host them next week, along with more than twenty (20) worldwide partners at Health Robotics' First Annual Partner Training in Trieste, Italy," stated Werner Rainer, Health Robotics' CEO.

CytoCare is the world's first and only robotic system designed for the safe and sterile preparation of patient-specific hazardous IV Admixtures for Chemotherapy, Monoclonal Antibody Therapy, and Gene Therapy. While other companies have for many years made promises of robotic IV automation products and even showcased staged "smoke and mirrors" marketing demonstrations of competing solutions that were supposed to exist as far back twenty years[1] ago, the fact remains that CytoCare is the only available solution that currently exists anywhere in the world to automatically compound and prepare ready-to-administer hazardous IV Admixtures, and that has been proven to work in a "live" hospital pharmacy environment, instead of just marketing brochures and theatrical shows.

"We are delighted that Health Robotics has given us this great opportunity as their exclusive strategic partner in our core market of Korea. CytoCare, the world's only real Oncology IV Admixtures Robot in existence, represents an ideal complement to BioRobotics' medical portfolio of Oncology Robotics' products and services, including Intuitive Surgical's daVinci(R) Surgery Robot. Just like Device Technologies Australia and PinnacleMed, I was very impressed with Health Robotics' technology and have received excellent references from other Asia-Pacific based daVinci(R) Surgery Robot's distribution partners, with whom we maintain regular contact. My contract negotiation meetings with Gaspar DeViedma last week were very productive and led to the execution of this very important milestone for our company", stated Bum Kyo Lee, CEO of BioRobotics.

About Innomed/BioRobotics:

Founded in 1995, Innomed/BioRobotics is currently the leading medical robotics supplier and the second largest medical importing business in the Republic of Korea with US $27M import volume during the year 2008. The company originally started in the Aesthetic laser surgery and Cryosurgery medical sectors and further expanded into robotic surgery in 2005. In only 4 years since the launch of Oncology Robotics in its core market, BioRobotics has already achieved twenty-four (24) installations of the daVinci(R) Surgical robot in the Republic of Korea. For more information, please visit: http://www.biorobotics.co.kr/

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation constitute the main building blocks of the company's vision to architect the I.V. Room of the Future on or before the year 2011. These Robots and software automation solutions have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, improve situational awareness of the IV Medication Management processes across the continuum of care, reduce the generational gap between rising patient volume/acuity and scarce pharmacy personnel, increase throughput, reduce waste, and contain costs. For more information, please visit http://www.health-robotics.com

    ---------------------------------
    [1] Am J Hosp Pharm 46(11): 2286-93 1989

    For additional information, please contact:

    Health Robotics S.r.l
    Gaspar G. DeViedma, General Counsel
    Altmanstrasse 9A, Bozen, Sud-Tyrol, Italy-39100
    USA: +1-609-980-7976
    EUROPE: +39-346-963-4934
    gaspar.deviedma@health-robotics.com

    BIOROBOTICS
    Bum Kyo Lee, CEO
    5F 5-36 Hyochang-dong, Yongsan-ku, Seoul, Korea
    Phone: +82-27015266
    bk@biorobot.co.kr


SOURCE Health Robotics


'/>"/>
SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  Patients in Alabama ... focused ultrasound (HIFU) therapy no longer have to travel out ... its partnership with Urology Centers of Alabama to ... FDA-cleared procedure for qualifying patients. Alabama ... in the treatment of prostate cancer using many different modalities. ...
(Date:2/5/2016)... 5, 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ... CEO, will be presenting at Source Capital Group,s 2016 Disruptive ... at 2:15 p.m. ET on Wednesday, February 10, ... discussion taking place at 3:15 p.m. ET. http://www.aethlonmedical.com ... hour after the conclusion of the live event. The panel ...
(Date:2/5/2016)... 5, 2016 Dehaier Medical Systems Ltd. ... "Company"), which develops, markets and sells medical devices ... China and international markets, today announced ... to concentrate the Company,s resources to develop its ... and to focus more on its major businesses. ...
Breaking Medicine Technology:
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, ... and organizations with the tools and information to lower the costs, and increase ... the cost of providing employee healthcare benefits by as much as 22%:, + ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... , ... February 06, 2016 ... ... 303-368-6225 , MEDIA ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE ... perioperative nurses in the world with an estimated 5000 perioperative nurses in ...
(Date:2/6/2016)... ... February 06, 2016 , ... US Sports Camps is ... (YUCC) . This event brings together top non-profit leaders, ultimate organizations, and coaches from ... Ultimate”. Valerio Iani, Bay Area Disc Program Director of Youth and Education, describes this ...
(Date:2/6/2016)... Viejo, CA (PRWEB) , ... February 06, 2016 , ... ... quickly and easily add warm color grades to their footage. A LUT is a ... every pixel's color to the corresponding color indicated by the table. By manipulating each ...
Breaking Medicine News(10 mins):